Home
ACTL Immunotherapy
Functional Mechanism
Advantages
Safety
Indications
Protocols
Steps
Patents
Translational Medicine
Treatment & Prevent
Conditions
Case Studies
Cooperative Hospital
Early Detection
Prevention
Nursing & Care
News
Partnership
About Us
Company Introduction
Our Culture
Milestones
Qualification & Honor
Team of Experts
Activities
Jobs
Contact Us
简体
繁体
英文
Coperate News
Coperate News
Industrial News
Policies & Regulations
02-03 2021
Prostate cancer undergoing ACTL targeted immunotherapy examination process
Prostate cancer (Prostatic Neoplasms, PCa in English) is the most common malignant tumor of th...
Details
02-03 2021
Colorectal cancer undergoes ACTL targeted cellular immunotherapy inspection process
Colorectal cancer is also called "colorectal cancer". The targets of ACTL targeted cellular im...
Details
02-03 2021
ACTL treatment of gastrointestinal tumors target antigens and introduction of typical clinical cases
1. Introduction to malignant tumors of the digestive tract Anti-tumor targeted cellular immunother...
Details
02-03 2021
The obvious advantages of ACTL treatment technology in anti-tumor neoadjuvant cell immunotherapy
In recent years, a new method of anti-tumor therapy has emerged in European and...
Details
02-03 2021
ACTL technology to treat tumors applicable to the population and treatment effect judgment index
1. ACTL technical indications and patient treatment guidelines 1. ACTL technology indication...
Details
<<
1
2
3
4
5
>>
10
